| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Parkinson's research reaches "pivotal" stage, but barriers remain | ||
| Fr | WHO directs antibiotic development to priority pathogens | ||
| Fr | PRISM BioLab partners with Receptor.AI for molecule discovery | ||
| Fr | PsiQuantum and National Cancer Center Japan partner on quantum computing | ||
| Do | Vima banks $100m in Series A to progress Parkinson's drug | ||
| Do | Eli Lilly finds impurity in compounded tirzepatide | ||
| Do | Bavarian Nordic and SII sign agreement for chikungunya vaccine production | ||
| Do | Curatis and Neupharma sign development agreement for corticorelin in Japan | ||
| Mi | FDA issues warning to Novo Nordisk on unreported semaglutide safety events | ||
| Mi | Eli Lilly to invest $3bn in China in anticipation of orforglipron approval | ||
| Mi | BioNTech co-founders step down to launch new mRNA venture | ||
| Mi | UK health authorities join forces to champion foreign infectious disease trials | ||
| Mi | Idorsia and Pharmalink sign agreement to distribute Quviviq | ||
| Mi | FDA approves GSK's Wellcovorin for cerebral folate deficiency | ||
| Di | FDA homes in on biosimilar accessibility in new draft guidance | ||
| Di | Junshi receives China's NMPA acceptance for toripalimab injection | ||
| Di | Novo and Hims & Hers become partners to end legal feud | ||
| Di | NewcelX and Eledon partner for NCEL-101 programme | ||
| Mo | GSK sells liver disease drug candidate to Alfasigma for $690m | ||
| Mo | Vinay Prasad to leave the FDA again | ||
| Mo | Sciwind secures China's NMPA approval for Ecnoglutide injection | ||
| Mo | BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment | ||
| 06.03. | Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal | ||
| 06.03. | J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma | ||
| 06.03. | Liberate Bio gains licences for myeloid-specific CAR design patents |